Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach

References

• Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduction Targeted Ther. 2020;5(1):293. doi:10.1038/s41392-020-00454-7.
   PubMed Web of Science ®Google Scholar
• Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, Rampotas A, Ambler G, Makris M. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med. 2021;385(18):1680–4. doi:10.1056/NEJMoa2109908.
   PubMed Web of Science ®Google Scholar
• Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt A-H, Skattør TH, Tjønnfjord GE, et al. Thrombosis and thrombocytopenia after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2124–30. doi:10.1056/NEJMoa2104882.
   PubMed Web of Science ®Google Scholar
• Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W, et al. Pathologic antibodies to platelet factor 4 after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021;384(23):2202–11. doi:10.1056/NEJMoa2105385.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–101. doi:10.1056/NEJMoa2104840.
   PubMed Web of Science ®Google Scholar
• Sadoff J, Davis K, Douoguih M. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination — response from the manufacturer. N Engl J Med. 2021;384(20):1965–66. doi:10.1056/NEJMc2106075.
   PubMed Web of Science ®Google Scholar
• Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med. 2021;384(20):1964–65. doi:10.1056/NEJMc2105869.
   PubMed Web of Science ®Google Scholar
• Clark RT, Johnson L, Billotti J, Foulds G, Ketels T, Heard K, Calvello Hynes E. Early outcomes of Bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26.COV2.S vaccination. Ann Emerg Med. 2021;78(4):511–14. doi:10.1016/j.annemergmed.2021.04.035.
   PubMed Web of Science ®Google Scholar
• Chong BH. Evolving concepts of pathogenesis of heparin-induced thrombocytopenia: diagnostic and therapeutic implications. Int J Lab Hematol. 2020;42(Suppl S1):25–32. doi:10.1111/ijlh.13223.
   PubMedGoogle Scholar
• Arepally GM, Cines DB. Pathogenesis of heparin-induced thrombocytopenia. Transl Res. 2020;225:131–40. doi:10.1016/j.trsl.2020.04.014.
   PubMed Web of Science ®Google Scholar
• Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. 2021;18(3):194–209. doi:10.1038/s41569-020-00469-1.
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120. doi:10.1186/s13045-020-00954-7.
   PubMed Web of Science ®Google Scholar
• Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD, Narayanan A, Majowicz SA, Kwong EM, McVicar RN, et al. SARS-CoV-2 infection depends on cellular Heparan Sulfate and ACE2. Cell. 2020;183(4):1043–57 e15. doi:10.1016/j.cell.2020.09.033.
   PubMed Web of Science ®Google Scholar
• Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, Wei D, Zhang Y, Sun X-X, Gong L, et al. CD147-Spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduction Targeted Ther. 2020;5(1):283. doi:10.1038/s41392-020-00426-x.
   PubMed Web of Science ®Google Scholar
• Lindhoff-Last E, Schoenborn L, Piorkowski M, Herold J, Greinacher A, Sheppard JA, et al. Heterogeneity of vaccine-induced immune thrombotic thrombocytopenia after ChAdox1 nCov-19 vaccination and safety of second vaccination with BNT162b2. Thromb Haemost. 2021;122(2):304–307. doi:10.1055/a-1701-2926.
   PubMedGoogle Scholar
• Strobel D, Haberkamp S, Zundler S. Portal vein thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdox1 nCov-19. Ultraschall in der Medizin - Eur J Ultrasound. 2021;42(05):551–52. doi:10.1055/a-1579-9303.
   Google Scholar
• De Michele M, Iacobucci M, Chistolini A, Nicolini E, Pulcinelli F, Cerbelli B, Merenda E, Schiavo OG, Sbardella E, Berto I, et al. Malignant cerebral infarction after ChAdox1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia. Nat Commun. 2021;12(1):4663. doi:10.1038/s41467-021-25010-x.
   PubMed Web of Science ®Google Scholar
• Cugno M, Macor P, Giordano M, Manfredi M, Griffini S, Grovetti E, De Maso L, Mellone S, Valenti L, Prati D, et al. Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdox1 nCov-19 vaccination. J Autoimmun. 2021;124:102728. doi:10.1016/j.jaut.2021.102728.
   PubMed Web of Science ®Google Scholar
• UniProt C. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–D9. doi:10.1093/nar/gkaa1100.
   PubMed Web of Science ®Google Scholar
• Li Y, Ma ML, Lei Q, Wang F, Hong W, Lai DY, Hou H, Xu Z-W, Zhang B, Chen H, et al. Linear epitope landscape of the SARS-CoV-2 spike protein constructed from 1,051 COVID-19 patients. Cell Rep. 2021;34(13):108915. doi:10.1016/j.celrep.2021.108915.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, Semple JW, Arnold DM, Godeau B, Lambert MP, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV -2 vaccination. Am J Hematol. 2021;96(5):534–37. doi:10.1002/ajh.26132.
   PubMed Web of Science ®Google Scholar
• Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021;39:101061. doi:10.1016/j.eclinm.2021.101061.
   PubMedGoogle Scholar
• Yang J, Zhang P, Cheng WX, Lu Y, Gang W, Ren G. Exposing structural variations in SARS-CoV-2 evolution. Sci Rep. 2021;11(1):22042. doi:10.1038/s41598-021-01650-3.
   PubMed Web of Science ®Google Scholar
• Goldman M, Hermans C. Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: possible paths to platelet factor 4 autoimmunity. PLoS Med. 2021;18(5):e1003648. doi:10.1371/journal.pmed.1003648.
   PubMed Web of Science ®Google Scholar